FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with - TheNote.app

Eli Lilly and Company News Releases

Follow

https://investor.lilly.com/news-releases/news-release-details/fda-approves-verzenior-abemaciclib-first-and-only-cdk46 investor.lilly.com

RSS Hunter • Oct 13, 2021